Cargando…

SUN-112 Arcuate 11-Betahydroxysteroid Dehydrogenase Type1 Regulates Energy Homeostasis

Introduction: Despite the ongoing increase in the prevalence of obesity, there are few licensed anti-obesity medications, and these therapies have limited efficacy and significant side effects. Therefore, new treatments are being developed, including 11-βhydroxysteroid dehydrogenase type1 (11βHSD1)...

Descripción completa

Detalles Bibliográficos
Autores principales:	Izzi-Engbeaya, Chioma, Ma, Yue, Buckley, Niki, Ratnasabapathy, Risheka, Richardson, Errol, Counsell, John, Fernandes-Freitas, Isabel, Norton, Mariana, Farooq, Gala, Mirza, Zainab, Cheetham, Sharon, Seckl, Jonathan, Murphy, Kevin, Dhillo, Waljit, Gardiner, James
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Endocrine Society 2019
Materias:	Adipose Tissue, Appetite, and Obesity
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6552872/ http://dx.doi.org/10.1210/js.2019-SUN-112

Ejemplares similares

Effects of corticosterone within the hypothalamic arcuate nucleus on food intake and body weight in male rats
por: Izzi-Engbeaya, Chioma, et al.
Publicado: (2020)

FRI007 Kisspeptin Does Not Affect Food Intake In Women With Overweight Or Obesity
por: Izzi-Engbeaya, Chioma, et al.
Publicado: (2023)

SAT-595 Early Weight Gain Impact onto the Arcuate Leptin Receptor Expressing Neurons Activity During Development
por: Zampieri, Thais T, et al.
Publicado: (2020)

SAT-112 Improvement of Pulmonary Function Test after Bariatric Surgery in Asthma Patients
por: Upala, Sikarin, et al.
Publicado: (2019)

PSUN112 Expression of Vitamin D Receptor Pathway Genes Across Tissues of Individuals with Obesity
por: Sisley, Stephanie, et al.
Publicado: (2022)

MON-112 Gelesis100 Reduces Insulin Resistance in Patients Who Are Overweight or Have Obesity with High Insulin Resistance: Results of the GLOW Study
por: Greenway, Frank, et al.
Publicado: (2019)

Hypothalamic arcuate nucleus glucokinase regulates insulin secretion and glucose homeostasis
por: Ma, Yue, et al.
Publicado: (2018)

OR23-4 Intestinal FFA2 and FFA3 Mediate Obesogenic Effects in Mice on a Western Diet
por: Gough, Sophie, et al.
Publicado: (2022)

LBODP002 Phase II Open-label Pilot Trial Of Liraglutide In Adolescents With Obesity After Vertical Sleeve Gastrectomy: Interim Results From 8-weeks Of Treatment
por: Fatima, Syeda Z, et al.
Publicado: (2022)

SAT-LB020 Use of Ultrasound to Characterize Abdominal Adipose Tissue Distribution and Its Impact on Metabolic Syndrome
por: Cuatrecasas Cambra, Guillem, et al.
Publicado: (2019)

MON-099 Age-Related Differences in Appetite Regulation among Adults with Obesity: More Than Just Hunger and PYY and Ghrelin? Oh My!
por: Iwamoto, Sean, et al.
Publicado: (2019)

MON-101 The LD Lync Study: Natural History Study of Lipodystrophy Syndromes: Early Lessons from the Pilot Data
por: Jalal Eldin, Abdelwahab, et al.
Publicado: (2019)

MON-114 Effect of Selective Mineralocorticoid Receptor Antagonist on liver Fat and Metabolism in Patients with Type 2 Diabetes: A Randomized Controlled Trail
por: Kistorp, Caroline, et al.
Publicado: (2019)

MON-092 Role of Genetic Variants of NNMT rs694539 and rs1941404, FTO rs1421085 and Irx3 rs3751723 Polymorphisms on Resting Energy Expenditure and BMI
por: Bañales Luna, Maciel, et al.
Publicado: (2019)

MON-113 Taste Sensitivity is Related to Incretin Response to Oral Glucose Challenge, Dietary Habits and Body Composition: A Novel Link with Energy Metabolism
por: Dagdelen, Selcuk, et al.
Publicado: (2019)

MON-106 Prevalence of Abdominal Obesity According to Different Cutoff Points in the Peruvian Population Living at Different Altitudes
por: Pajuelo-Ramirez, Jaime, et al.
Publicado: (2019)

MON-115 Acute BAT Activation Improves Glucose Tolerance and Beta-Cell Secretion and Facilities Lipid over Glucose Utilization in Obese Metabolically Healthy Males
por: Bertozzi, Beatrice, et al.
Publicado: (2019)

MON-098 FSH and Body Composition in Older Adults
por: Woods, Gina, et al.
Publicado: (2019)

MON-104 Defining the Contribution of Weight to the Extent of Metabolic Disease in FPLD: Insights from a Retrospective "Matched" Case-Control Study
por: Koo, Eden, et al.
Publicado: (2019)

SAT-102 Self-efficacy As A Predictor Of Weight Loss In Veterans With Obesity Participating In Medical Weight Management.
por: Parziale, Andrew, et al.
Publicado: (2019)

SAT-LB017 Anthropometric Imaging and Biological Markers of Adiposity and Aldosterone among African Americans: The Jackson Heart Study
por: Lee, Grace, et al.
Publicado: (2019)

MON-096 Body Composition in Patients with Craniopharyngioma: Is DXA-Scanning Necessary for Evaluating the Metabolic Syndrome?
por: van Santen, Selveta, et al.
Publicado: (2019)

MON-118 Biochemical and Clinical Correlates of Subcutaneous Adipose mRNA Transcript Levels in Men with T2DM
por: Tun, Nyo Nyo, et al.
Publicado: (2019)

MON-110 A Natural Compound Isolated from Schisandra Chinensis Fruit Has a Beneficial Effect in a Fly Model of Obesity
por: Cheon, Chong Kun, et al.
Publicado: (2019)

MON-109 Identifying Limiting Factors to Weight Loss and Prevention of Comorbidities in a Patient Population with Obesity
por: Johns, Allison, et al.
Publicado: (2019)

MON-LB018 Depot-Specific Differences in Adipose Tissue Morphology with Laron Syndrome
por: Geitgey, Delaney, et al.
Publicado: (2019)

MON-LB016 Sex and Sex Steroid Effects on Brown Adipose Tissue Temperature in Healthy Humans
por: Fuller-Jackson, John-Paul, et al.
Publicado: (2019)

MON-097 Angiopoietin-Like Protein 8 (ANGPTL8) Levels in Thai Subjects with Hyperalphalipoproteinemia
por: Kaewkrasaesin, Chatchon, et al.
Publicado: (2019)

MON-117 The Association of Adipocytokine Concentrations with Obesity and Metabolic Health in a Mexican-American Border Populations
por: Al-Dallal, Reem, et al.
Publicado: (2019)

MON-111 Amenorrhea In Exercising Women Is Associated With A Greater Reduction In Post-prandial Ghrelin
por: Koltun, Kristen, et al.
Publicado: (2019)

MON-094 Aromatase Inhibitors and Weight Loss in Severely Obese Male Veterans with Hypogonadism: A Randomized Clinical Trial
por: Colleluori, Georgia, et al.
Publicado: (2019)

MON-091 Profound and Sustained Weight Loss in Men With Hypogonadism and Obesity Receiving Long-Term Testosterone Therapy (TTh) with Testosterone Undecanoate Injections (TU): 10-Year Data from a Registry Study in a Urological Setting
por: Haider, Karim, et al.
Publicado: (2019)

MON-107 Endothelium Derived Factors Influence Differentiation of Fat Derived Stromal Cells
por: Kundu, Nabanita, et al.
Publicado: (2019)

MON-102 Nonclinical Development of AZP-531 (Livoletide): A Peptide Analog of Unacylated Ghrelin for the Treatment of Hyperphagia in Prader-Willi Syndrome
por: Milano, Stephane, et al.
Publicado: (2019)

MON-105 Sedentary Behavior and Light Physical Activity were Related with Percent Body fat in Elderly Type 2 Diabetes
por: Han, Kyung Ah, et al.
Publicado: (2019)

MON-100 Unique miRNA Signature in HIV Lipodystrophy with Reduced Adipose Dicer Expression
por: Srinivasa, Suman, et al.
Publicado: (2019)

MON-116 Liposuction for Lipedema (Persistent Fat) in the US Improves Quality of Life
por: Cobos, Leopoldo, et al.
Publicado: (2019)

MON-120 Effect of Weight Loss on Physical Function Measured by the 6-Minute Walking Distance Test in Individuals with Obesity: Results from the SCALE IBT Trial of Liraglutide 3.0 Mg
por: Rubino, Domenica, et al.
Publicado: (2019)

MON-LB017 Natural Genetic Variation in Humans Determines Basal and PPAR-Inducible Expression of PM20D1, a Putative Thermogenic Gene
por: Benson, Kiara, et al.
Publicado: (2019)

MON-LB021 Effects of Intranasal Oxytocin on the Fasting Serum Proteome in Healthy Lean and Obese Men
por: Harshman, Stephanie, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_0cchh8k5soc2afdmlhtuj4iis7